Day One Biopharmaceuticals, Inc. (DAWN) Earnings
|
Expand Research on DAWN
| Next EPS Date | 8/5/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +35.1% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +4.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | -$0.25 | N/A | N/A | $55.06M | = | N/A | N/A | ||
| 2/24/26 | Q425 | $0.00 | -$0.19 | +$0.19 | $52.8M | $45.86M | = |  | | Details | |
| 11/4/25 | Q325 | -$0.19 | -$0.29 | +$0.10 | $39.8M | $38.19M | N/A | | | Details | |
| 8/5/25 |
Q225 | N/A | -$0.35 | N/A | N/A | $35.56M | N/A | N/A | N/A | ||
| 5/6/25 | Q125 | -$0.35 | -$0.42 | +$0.07 | $30.76M | $31.34M | N/A | | | Details | |
| 2/25/25 |
Q424 | N/A | -$0.46 | N/A | N/A | $26.64M | N/A | N/A | N/A | ||
| 10/30/24 |
Q324 | N/A | -$0.61 | N/A | N/A | $15.05M | N/A | N/A | N/A | ||
| 8/6/24 | Q224 | N/A | -$0.67 | N/A | N/A | $1.02M | N/A | N/A | N/A |
